Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout

NCT01078389 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Joint Damage

Interventions

DRUG: Febuxostat
DRUG: Placebo for Febuxostat

Sponsor

Takeda